98.9%
of US oncologists polled for a recent survey say they have experienced
shortages of cancer drugs in the last year, and that as a result of the
shortages, cancer has progressed in more than 60% of their patients.
Over 70% of patients have experienced more severe side effects as a
result of the shortages, add the oncologists, responding to a survey conducted
by the Community Oncology Alliance (COA). Almost half of the physicians also
reported that they were seeing more than one patient per day affected by a drug
shortage, and 58.2% say the shortage of cancer drugs is increasing.
In addition, over 80% of the patients and more than 90% of the practices
affected by a cancer drug shortage experienced a more severe financial burden,
says the COA.
I do not
understand the situation: the logic should be following:
Cancer medicine
is expensive and makes huge profit for Big Pharma
→
Every medicine vial sold
gives a profit to Big Pharma
→
There should be no any medicine shortage due to
the shortage presupposes shortage of sales and profit.
But the
phenomenon of shortage does exist which means that something in our scheme is
missing… What is missing? So far I do not know but I am convinced that somebody
has to get benefits (political if not direct financial and economic ones) from
this situation and I guess it should be Big Pharma. In which way? It will be
clear very soon…
No comments:
Post a Comment